4//SEC Filing
INFINITY PHARMACEUTICALS, INC. 4
Accession 0001209191-14-071692
CIK 0001113148operating
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:15 PM ET
Size
10.0 KB
Accession
0001209191-14-071692
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2014-11-26$15.00/sh−4,736$71,040→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2014-11-26−4,736→ 0 totalExercise: $2.04From: 2005-05-10Exp: 2015-05-10→ Common Stock (4,736 underlying) - Exercise/Conversion
Common Stock
2014-11-26$2.04/sh+4,736$9,661→ 4,736 total
Holdings
- 6,543.802(indirect: By 401(k))
Common Stock
Footnotes (3)
- [F1]The acquisition and disposition reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- [F2]The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 27, 2013.
- [F3]This stock option was granted under the issuer's Pre-Merger Stock Incentive Plan, which permits the early exercise of unvested stock options in exchange for shares of restricted stock that are subject to a right of repurchase by the issuer that lapses in accordance with the vesting schedule of the original option. This option is fully vested.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001113148
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:15 PM ET
- Size
- 10.0 KB